亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors

彭布罗利珠单抗 医学 内科学 肿瘤科 伴生诊断 免疫组织化学 置信区间 PD-L1 病理 癌症 免疫疗法
作者
Antonio Marchetti,Massimo Barberis,Renato Franco,Graziano De Luca,Marta Pace,Stefania Staibano,Marco Volante,Fiamma Buttitta,Elena Guerini‐Rocco,Luisella Righi,Tommaso D’Antuono,Giorgio Vittorio Scagliotti,Carmine Pinto,Gaetano De Rosa,Mauro Papotti
出处
期刊:Journal of Thoracic Oncology [Elsevier]
卷期号:12 (11): 1654-1663 被引量:80
标识
DOI:10.1016/j.jtho.2017.07.031
摘要

Among the several agents targeting the programmed cell death 1 (PD-1) pathway, pembrolizumab is currently the only one approved for the treatment of patients with NSCLC in association with a companion diagnostic assay, the anti-PD-L1 immunohistochemical (IHC) 22C3 PharmDx (Agilent Technologies, Santa Clara, CA) using the Dako Autostainer (Dako, Carpinteria, CA). However, the Dako platform is not present in each pathology department, and this technical limitation is a major problem for the diffusion of the PD-L1 IHC predictive test for pembrolizumab.The Italian Society of Anatomic Pathology and Cytopathology and the Italian Association of Medical Oncology in an independent, multicenter study compared the in vitro diagnostics PD-L1 IHC 22C3 pharmDx test (Agilent) on the Dako Autostainer and the in vitro diagnostics Ventana PD-L1 (SP263) test on the Ventana BenchMark platform (Ventana Medical Systems, Tucson, AZ). Using serial sections from tissue microarrays, 100 lung adenocarcinomas were locally stained and scored in four centers with the same antibody batches.A high analytical correlation (more than 90% at the lower 95% confidence interval [CI] value) between PD-L1 expression levels obtained with the 22C3 and SP263 assays was observed. At the proposed clinically relevant cutoffs (≥50% and ≥1%), the overall concordances between 22C3 and SP263 data were 0.99 (95% CI: 0.96-1) and 0.80 (95% CI: 0.68-0.91), respectively. The lower agreement between data obtained with the 22C3 and SP263 clones at the cutoff of 1% or higher was mainly related to the lower (about 80%) interrater agreement at this cutoff with each clone.These results indicate a high correlation between PD-L1 IHC expression data obtained with the Agilent PD-L1 IHC 22C3 pharmDx and the Ventana PD-L1 (SP263) tests in NSCLC and suggest that the two assays could be utilized interchangeably as an aid to select patients for first-line and second-line treatment with pembrolizumab and potentially with other anti-PD-1/PD-L1 checkpoint inhibitors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SciGPT应助王十三采纳,获得10
1秒前
22秒前
you发布了新的文献求助10
27秒前
香妃发布了新的文献求助10
29秒前
you完成签到,获得积分10
33秒前
33秒前
丘比特应助you采纳,获得10
38秒前
39秒前
JamesPei应助科研通管家采纳,获得10
39秒前
46秒前
48秒前
王十三发布了新的文献求助10
50秒前
1分钟前
科研人完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
花半里里发布了新的文献求助10
1分钟前
wanci应助花半里里采纳,获得10
1分钟前
小不点、大迷糊完成签到,获得积分10
1分钟前
ZhangDaying完成签到 ,获得积分10
1分钟前
1分钟前
小北发布了新的文献求助10
1分钟前
Akim应助开心小阮采纳,获得10
1分钟前
快哒哒哒完成签到,获得积分10
1分钟前
struggling2026完成签到 ,获得积分10
1分钟前
吕懿发布了新的文献求助10
2分钟前
yaoyaoyao完成签到 ,获得积分10
2分钟前
英俊的铭应助吕懿采纳,获得10
2分钟前
2分钟前
pengrui0911完成签到 ,获得积分10
2分钟前
开心小阮发布了新的文献求助10
2分钟前
哈喽发布了新的文献求助20
2分钟前
飞艇完成签到 ,获得积分10
2分钟前
2分钟前
晓宇完成签到 ,获得积分10
2分钟前
JamesPei应助livialiu采纳,获得10
2分钟前
Cha完成签到 ,获得积分10
3分钟前
852应助炸酱面有故事采纳,获得10
3分钟前
3分钟前
高分求助中
Un calendrier babylonien des travaux, des signes et des mois: Séries iqqur îpuš 1036
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
行動データの計算論モデリング 強化学習モデルを例として 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2545351
求助须知:如何正确求助?哪些是违规求助? 2175631
关于积分的说明 5600124
捐赠科研通 1896314
什么是DOI,文献DOI怎么找? 946215
版权声明 565334
科研通“疑难数据库(出版商)”最低求助积分说明 503541